Sensitive liquid chromatography–tandem mass spectrometry method for the determination of loratadine and its major active metabolite descarboethoxyloratadine in human plasma

References

Page 1

	Year	Citations
Liquid Chromatography/Mass Spectrometry Methods for Distinguishing <i>N</i>-Oxides from Hydroxylated Compounds Ragu Ramanathan, A.-D. Su, N. Alvarez, Analytical Chemistry Water LossEngineeringHydroxylated CompoundsOrganic ChemistryLiquid Chromatography/mass Spectrometry	2000	132
Pharmacokinetics and Dose Proportionality of Loratadine James Hilbert, Elaine Radwanski, Ray Weglein, The Journal of Clinical Pharmacology	1987	106
Selective displacement of [3H]mepyramine from peripheral vs. central nervous system receptors by loratadine, a non-sedating antihistamine Ho-Sam Ahn, Allen Barnett European Journal of Pharmacology AllergyMedicineAnesthetic MechanismNeuropharmacologySelective Displacement	1986	74
Sensitive gas—liquid chromatographic method for the determination of loratadine and its major active metabolite, descarboethoxyloratadine, in human plasma using a nitrogen—phosphorus detector Richard M. Johnson, Jeffrey E. Christensen, Chin‐Chung Lin Journal of Chromatography B Biomedical Sciences and Applications BiochemistryGas ChromatographyMedicineBioanalysisMajor Active Metabolite	1994	73
Determination of loratadine and pheniramine from human serum by gas chromatography-mass spectrometry Jens Martens Journal of Chromatography B Biomedical Sciences and Applications Gas ChromatographyMedicineBioanalysisMass SpectrometryChemical Pathology	1995	52
Loratadine: Multiple‐Dose Pharmacokinetics Elaine Radwanski, James Hilbert, Samson Symchowicz, The Journal of Clinical Pharmacology	1987	48
Pharmacologic evaluation of loratadine (SCH 29851), chlorpheniramine and placebo Randal L. Batenhorst, Alice S. Batenhorst, David A. Graves, European Journal of Clinical Pharmacology MedicineClinical PharmacologyPharmacotherapyPharmacologySch 29851	1986	35

Page 1